Sign in
Phase 2a Study of CU06-1004, an Oral Endothelial Dysfunction Blocker for the Treatment of Diabetic Macular Edema
Victor Hugo Gonzalez, MD
Updates from the Field
2024
Genetic Variants Associated With Anti-VEGF Drug Response in Neovascular AMD Patients in the View Trial
Nancy M. Holekamp, MD, FASRS
2016
Impact of Retinal Ischemia on Visual Acuity Outcomes
Michael Peter Fielden, MD, FRCS(C)
Category: Miscellaneous